Search published articles


Showing 2 results for Ardebili

Abdollah Ardebili , Malihe Talebi , Abdolaziz Rastegar Lari ,
Volume 10, Issue 1 (Jan,Feb 2016 2016)
Abstract

Abstract

      Background and Objective: Due to the continuous increase of multidrug-resistant Acinetobacter baumannii strains around the world, decision making for an effective treatment of infections caused by this organism depends on the results of antimicrobial susceptibility tests. In this study, the validity of disk diffusion and E-test methods was assessed by their comparison with the reference method of microbroth dilution for three antibiotics of tetracycline, doxycycline and minocycline.

     Methods: Total of 68 A. baumannii isolates were obtained from patients hospitalized in the burn center of Shahid Motahari Hospital in Tehran, Iran. Susceptibility of the Acinetobacter isolates was evaluated using the disk diffusion, E-test and microbroth dilution methods, according to the guidelines of Clinical and Laboratory Standards Institute.

     Results: Among the isolates, 82.3% were tetracycline-resistant (with minimum inhibitory concentration 50 (MIC50) and MIC90 of 32 and more than 32 µg/ml, respectively and 41.2% were doxycycline-resistant (with MIC50 and MIC90 of 4 and more than 32 µg/ml, respectively). Minocycline, with resistance of up to 13.3% (MIC50 and MIC90 of 1 and 8 µg/ml, respectively) showed the highest antimicrobial activity against the A. baumannii isolates. Antimicrobial susceptibility of bacteria was different depending on the type of methods used. No very major error was observed in any of the methods of susceptibility testing. Overall, the level of major and minor errors in the E-test was lower than the disk diffusion method.

     Conclusion: The results of this study indicate that minocycline has notably high antimicrobial activity against A. baumannii compared to other antibiotics of the tetracycline group.


Abdoljalil Eiri, Hami Kaboosi, Farhad Niknejad, Abdollah Ardebili, Hamid Reza Joshaghani,
Volume 16, Issue 4 (Jul-Aug 2022)
Abstract

Background and objectives: Aflatoxin B1 (AFB1) is the most toxic aflatoxin produced by a large number of Aspergillus species. Successful detoxification of this toxin is an important attempt to improve community health. The aim of this study was to evaluate reducing effects of yeasts isolates from kefir and traditional kefir-like fermented beverages on AFB1 in a broth medium.
Methods: Polymerase chain reaction-sequencing was carried out to identify the yeast isolates from kefir and kefir-like beverages. Effects of the isolates on AFB1 adsorption and biotransformation in peptone dexterose broth medium were evaluated by using high performance liquid chromatography.
Results: Saccharomyces cerevisiae and Kluyveromyces marxianus were isolated from kefir and kefir-like beverages and resulted in 46% and 53% AFB1 adsorption, respectively. The isolates 27Y and 2Y caused 7% toxin biotransformation, while 10% toxin biotransformation was achieved by the isolate 18Y. 
Conclusion: Our results indicate that the yeast isolates from kefir and traditional kefir-like products can bind to and detoxify AFB1, thereby reducing its harmful effects.

Page 1 from 1     

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.